Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients

BACKGROUND: Identifying lung cancer patients at an increased risk of getting SARS-CoV-2-related complications will facilitate tailored therapy to maximize the benefit of anti-cancer therapy, while decreasing the likelihood of COVID-19 complications. This analysis aimed to identify the characteristic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganti, Apar Kishor, Fillmore, Nathanael R., Bihn, John, La, Jennifer, Brophy, Mary T., Do, Nhan V., Kelley, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977088/
https://www.ncbi.nlm.nih.gov/pubmed/36859565
http://dx.doi.org/10.1007/s10147-023-02311-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977088/
https://www.ncbi.nlm.nih.gov/pubmed/36859565
http://dx.doi.org/10.1007/s10147-023-02311-3

Ejemplares similares